×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Events
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Cure Connections

Following a discussion on where to find reliable information on chronic lymphocytic leukemia (CLL) and treatment, participants share their closing thoughts.
Participants highlight the importance of proper support and communication while receiving therapy for chronic lymphocytic leukemia (CLL).
 
Considerations for what happens when a patient progresses with chronic lymphocytic leukemia (CLL).
 
Shared insight on the long-term nature of treatment for chronic lymphocytic leukemia (CLL).
 
More

Cure Expert Connections

Key opinion leaders close the discussion by considering the future of cutaneous squamous cell carcinoma (CSCC) and promising emerging regimens.
Experts in skin-care management discuss the role of the multidisciplinary team to provide patients with the best treatment strategy.
A discussion of the possibility of managing organ transplant populations with immunotherapy.
Experts in the treatment of skin cancers discuss the management of immunotherapy toxicities in the inpatient setting.
More

Cure TV

Kristie L. Kahl
“When time passes, and you look back it seems like a distant memory.”
 
Ryan McDonald and Timothy Burns
“One FDA approval that we were quite excited about (is Tabrecta). And I've actually already put some patients on it; it's a very good drug,” Dr. Timothy Burns said in a recent interview.
 
Ian Macleod
“At 34, I have another chance to live the rest of my life with a consciousness that there's great purpose in the pain.”
 
Kristie L. Kahl
“You have to speak up. What you don’t say is the most predictive of the care you don’t get.”
 
More

Cure Speaking Out

Kristie L. Kahl and David Alexander
David Alexander, from the MPN Education Foundation, discusses MPNs as a chronic disease and learning how to live a new normal.
 
Kristie L. Kahl and Dr. Ruben Mesa
Dr. Ruben Mesa, from the MPN Education Foundation, discusses various treatment options for myeloproliferative neoplasms, and highlights how advances in research can help patients with the disease and beyond.
 
Kristie L. Kahl and Dr. Ruben Mesa
Dr. Ruben Mesa, from the MPN Education Foundation, discusses MPN diagnoses, and why it is key for patients and caregivers to understand the disease to have improved conversations with physicians.
 
Kristie L. Kahl and Dr. Ruben Mesa
Dr. Ruben Mesa, from the MPN Education Foundation, discusses the three types of myeloproliferative neoplasms and how they differ from one another.
 
More
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×